Centessa Pharmaceuticals plc (CNTA) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-24

Centessa Pharmaceuticals plc (CNTA) has filed 18 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-24. 3 Form 8-K material event filings were reported by CNTA in the last 90 days. InsiderAlpha tracks every CNTA SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Centessa Pharmaceuticals plc (CNTA)

SIC classificationPharmaceutical Preparations (SIC 2834)
SEC CIK0001847903

90-Day SEC Filing Activity

Form 4 filings (90d)18
Form 8-K filings (90d)3
Latest Form 4 filing2026-06-24

Recent CNTA Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
Deferiere RaphaelChief Accounting OfficerD — Derivative transaction11.0K——SEC
Anderson Karen M.Chief People OfficerD — Derivative transaction62.1K——SEC
Bush Tia LChief Technology & Quality OfcD — Derivative transaction148.0K——SEC
Crowley John JChief Financial OfficerD — Derivative transaction45.0K——SEC
HUSSAIN IQBAL JChief Legal OfficerD — Derivative transaction117.6K——SEC
INDEX VENTURES LIFE VI (JERSEY) L.P.InsiderS — Open-market sale149.4K——SEC
Medicxi Ventures Management (Jersey) LtdInsiderS — Open-market sale3.94M——SEC
HUSSAIN IQBAL JChief Legal OfficerD — Derivative transaction5.5K——SEC
Medicxi Ventures Management (Jersey) LtdInsiderS — Open-market sale55.7K——SEC
Medicxi Ventures Management (Jersey) LtdInsiderS — Open-market sale4.40M——SEC
Medicxi Ventures Management (Jersey) LtdInsiderS — Open-market sale281.2K——SEC
Medicxi Ventures Management (Jersey) LtdInsiderS — Open-market sale11.20M——SEC
Medicxi Ventures Management (Jersey) LtdInsiderS — Open-market sale93.5K——SEC
INDEX VENTURES LIFE VI (JERSEY) L.P.InsiderS — Open-market sale9.81M——SEC
Kanes StephenChief Medical OfficerD — Derivative transaction120.0K——SEC

All transactions sourced from SEC EDGAR Form 4 filings for Centessa Pharmaceuticals plc (CNTA). Updated in real time as new filings are submitted to the SEC.

Most-Active CNTA Insiders — Last 90 Days

InsiderForm 4 filingsTotal transaction value
HUSSAIN IQBAL J10—
Accardi Mario Alberto8$24K
Weinhoff Gregory M8—
Bush Tia L7—
Anderson Karen M.6—

Recent CNTA Form 8-K Material Events

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CNTA insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

CNTA Insider Trading — FAQ

What is the latest insider trade for CNTA?
Centessa Pharmaceuticals plc (CNTA) had 18 insider filings in the last 90 days, with the most recent on 2026-06-24. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying CNTA stock?
0 insider purchases of CNTA were filed in the last 90 days.
How many insiders are selling CNTA stock?
0 insider sales of CNTA were filed in the last 90 days.
Where can I see CNTA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every CNTA SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live CNTA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.